Contact us for information regarding our sample policy
Western Europe North America South America Eastern Europe Middle East Asia Central America Australia Africa
All India
Product Description
Aflibercept is a biopharmaceutical drug invented by Regeneron Pharmaceuticals, approved in the United States and Europe for the treatment of wet macular degeneration under the trade name Eylea, and for metastatic colorectal cancer as Zaltrap.